FDW
ALNY icon

Fourth Dimension Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Fourth Dimension Wealth’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.62K Buy
22
+6
+38% +$1.81K ﹤0.01% 515
2026
Q1 		$5.29K Hold
16
– – ﹤0.01% 472
2025
Q4 		$6.36K Sell
16
-557
-97% -$247K ﹤0.01% 456
2025
Q3 		$261K Sell
573
-16
-3% -$6.51K 0.1% 115
2025
Q2 		$192K Buy
589
+85
+17% +$23.5K 0.08% 130
2025
Q1 		$136K Buy
+504
New +$130K 0.07% 130

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fourth Dimension Wealth's ALNY Position: Q2 2026 in Review

Fourth Dimension Wealth increased its Alnylam Pharmaceuticals (ALNY) stake by 38% in Q2 2026, buying an estimated $1.81K and bringing the position to 22 shares worth $6.62K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Fourth Dimension Wealth first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $261K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Fourth Dimension Wealth held 22 shares of Alnylam Pharmaceuticals worth $6.62K as of Q2 2026.
  • Fourth Dimension Wealth bought 6 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.81K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Fourth Dimension Wealth's portfolio in Q2 2026, its #515 holding.
  • Fourth Dimension Wealth first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Fourth Dimension Wealth's Alnylam Pharmaceuticals position peaked at $261K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.